Medical Developments International

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Drug Manufacturers-Specialty & Generic
  • Company website

Company description

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.

Financial highlights

Market Capitalization$72.0649 million
P/E Ratio0
P/E Growth Ratio0
Book Value0.942
Dividend Per Share0
Earnings Per Share-0.07
EBITDA-15,890
Profit Margin-0.1735
Operating Margin TTM-0.5351
Return on Assets TTM-0.1118
Return on Equity TTM-0.0809
Revenue TTM32,337

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
2003-06-30 5,475 5,475 347
2004-06-30 3,048 1,040 2,008 1,570
2005-06-30 5,404 1,926 3,478 3,585
2006-06-30 6,605 2,235 4,370 3,311
2007-06-30 7,460 2,507 4,953 3,438
2008-06-30 9,219 3,495 5,724 4,812
2009-06-30 8,727 3,031 5,696 4,979
2010-06-30 8,296 2,992 5,304 4,441
2011-06-30 10,206 3,669 6,537 4,654
2012-06-30 11,313 3,467 7,846 4,657
2013-06-30 11,733 3,402 8,331 5,468
2014-06-30 9,370 3,050 6,320 5,888
2015-06-30 11,608 3,554 8,054 6,290
2016-06-30 14,373 4,260 10,113 10,004
2017-06-30 16,446 5,764 10,682 11,458
2018-06-30 17,461 5,097 12,364 13,706
2019-06-30 20,876 6,692 14,184 15,276
2020-06-30 22,535 7,543 14,992 17,490
2021-06-30 25,272 6,173 19,099 28,820
2022-06-30 22,369 6,735 15,634 30,903
2023-06-30 32,337 10,125 22,212 42,485

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
2003-06-30 980 11,633 4,131 1,500 7,502
2004-06-30 1,701 12,472 4,098 1,500 2,000 7,893
2005-06-30 542 11,555 3,155 500 2,000 7,893
2006-06-30 1,020 12,499 2,627 44 2,000 8,092
2007-06-30 335 12,115 1,094 250 8,092
2008-06-30 473 13,189 1,388 7,985
2009-06-30 257 13,392 1,578 7,293
2010-06-30 1,782 14,215 1,503 7,293
2011-06-30 3,541 16,713 2,258 7,293
2012-06-30 3,483 19,136 2,967 9,354
2013-06-30 768 20,259 4,515 1,356 88 10,559
2014-06-30 1,659 22,560 6,736 3,089 573 10,946
2015-06-30 954 22,988 5,581 92 1,019 10,946
2016-06-30 5,620 41,239 22,214 143 338 11,916
2017-06-30 1,691 41,764 20,164 146 283 15,008
2018-06-30 794 49,548 28,507 102 9,150 16,121
2019-06-30 25,620 84,801 40,213 91 91 40,410
2020-06-30 15,544 84,759 41,421 417 0 40,954
2021-06-30 36,277 100,175 31,873 337 0 76,895
2022-06-30 20,398 92,220 34,922 348 76,992
2023-06-30 24,661 101,313 19,998 352 105,729

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2004-06-30 481 401 1,701
2005-06-30 168 569 -1,159 1,701 542 142
2006-06-30 797 1,152 478 542 1,020
2007-06-30 1,207 1,267 -685 1,020 335
2008-06-30 891 1,228 138 335 473
2009-06-30 810 1,284 -216 473 257
2010-06-30 879 1,811 1,525 257 1,782
2011-06-30 1,743 3,031 1,759 1,782 3,541
2012-06-30 2,704 3,198 -58 3,541 3,483 1,221
2013-06-30 2,309 977 -2,715 3,483 768 2,309
2014-06-30 875 1,295 891 768 1,659 760
2015-06-30 1,529 3,359 -705 1,659 954 623
2016-06-30 1,569 12,067 4,666 954 5,620 623
2017-06-30 1,820 4,011 -3,929 5,620 1,691 1,238
2018-06-30 243 1,790 -897 1,691 794 1,239
2019-06-30 1,038 21,271 24,826 794 25,620 1,717
2020-06-30 379 172 -10,076 25,620 15,544 2,065
2021-06-30 -12,565 -8,890 20,733 15,544 36,277 0
2022-06-30 -12,407 -7,868 -15,879 36,277 20,398
2023-06-30 -5,609 -17,061 4,263 20,398 24,661